In addition, understanding the circadian state of the tumor itself, including whether it has a MYC-disrupted molecular circadian clock or a more intact clock as a result of MYC inhibition, will be critical to understanding when to best deliver chemotherapy to best target the tumor while limiting patient toxicity. Here, MYC is linked to neoplasm.